메뉴 건너뛰기




Volumn 16, Issue 6, 2015, Pages 807-820

Tumor infiltrating lymphocytes in ovarian cancer

Author keywords

Immunosuppression; Immunotherapy; Ovarian cancer; Prognostic factors; Regulatory T cells; Tumor infiltrating lymphocytes

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CANCER THERAPY; CELL THERAPY; CLINICAL TRIAL (TOPIC); FEMALE; HUMAN; LYMPHOCYTE FUNCTION; META ANALYSIS (TOPIC); NONHUMAN; OVARY CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; ANIMAL; IMMUNOLOGY; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; METABOLISM; MORTALITY; OVARIAN NEOPLASMS; PATHOLOGY; PROGNOSIS; TREATMENT OUTCOME;

EID: 84943810799     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2015.1040960     Document Type: Review
Times cited : (281)

References (149)
  • 4
    • 84878340223 scopus 로고    scopus 로고
    • Epithelial ovarian cancer: Initial surgical management
    • Goff B, ed, Waltham, MA
    • Mann WJ, Chalas EJ, Valea FA. Epithelial ovarian cancer: Initial surgical management. In: Goff B, ed. In: UpToDate. Waltham, MA., 2013.
    • (2013) UpToDate
    • Mann, W.J.1    Chalas, E.J.2    Valea, F.A.3
  • 5
    • 0035874949 scopus 로고    scopus 로고
    • Regulatory CD4(C)CD25(C) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
    • PMID: 11406550
    • Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH. Regulatory CD4(C)CD25(C) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 2001; 61: 4766-72; PMID: 11406550.
    • (2001) Cancer Res , vol.61 , pp. 4766-4772
    • Woo, E.Y.1    Chu, C.S.2    Goletz, T.J.3    Schlienger, K.4    Yeh, H.5    Coukos, G.6    Rubin, S.C.7    Kaiser, L.R.8    June, C.H.9
  • 6
    • 84879097208 scopus 로고    scopus 로고
    • Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study
    • PMID: 23578540
    • Landrum LM, Java J, Mathews CA, Lanneau GS, Jr., Copeland LJ, Armstrong DK, Walker JL. Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study. Gynecol Oncol 2013; 130: 12-8; PMID: 23578540; http://dx. doi. org/10. 1016/j. ygyno. 2013. 04. 001.
    • (2013) Gynecol Oncol , vol.130 , pp. 12-18
    • Landrum, L.M.1    Java, J.2    Mathews, C.A.3    Lanneau, G.S.4    Copeland, L.J.5    Armstrong, D.K.6    Walker, J.L.7
  • 8
    • 84899104459 scopus 로고    scopus 로고
    • Harnessing the immune system to provide longterm survival in patients with melanoma and other solid tumors
    • Eggermont A, Robert C, Soria JC, Zitvogel L. Harnessing the immune system to provide longterm survival in patients with melanoma and other solid tumors. Oncoimmunology 2014; 3: e27560.
    • (2014) Oncoimmunology , vol.3
    • Eggermont, A.1    Robert, C.2    Soria, J.C.3    Zitvogel, L.4
  • 9
    • 84894107349 scopus 로고    scopus 로고
    • New insights into cancer immunoediting and its three component phases-elimination, equilibrium and escape
    • Mittal D, Gubin MM, Schreiber RD, Smyth MJ. New insights into cancer immunoediting and its three component phases-elimination, equilibrium and escape. Curr Opin Immunol 2014; 27C: 16-25; http://dx. doi. org/10. 1016/j. coi. 2014. 01. 004.
    • (2014) Curr Opin Immunol , vol.27 , pp. 16-25
    • Mittal, D.1    Gubin, M.M.2    Schreiber, R.D.3    Smyth, M.J.4
  • 11
    • 84857746620 scopus 로고    scopus 로고
    • Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma
    • PMID: 22266112
    • Erdag G, Schaefer JT, Smolkin ME, Deacon DH, Shea SM, Dengel LT, Patterson JW, Slingluff CL, Jr. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer research 2012; 72: 1070-80; PMID: 22266112; http://dx. doi. org/10. 1158/0008-5472. CAN-11-3218.
    • (2012) Cancer research , vol.72 , pp. 1070-1080
    • Erdag, G.1    Schaefer, J.T.2    Smolkin, M.E.3    Deacon, D.H.4    Shea, S.M.5    Dengel, L.T.6    Patterson, J.W.7    Slingluff, C.L.8
  • 13
    • 0026276653 scopus 로고
    • Immune effect of tumor-infiltrating lymphocytes and its relation to the survival rate of patients with ovarian malignancies
    • PMID: 1668016
    • Ma D, Gu MJ. Immune effect of tumor-infiltrating lymphocytes and its relation to the survival rate of patients with ovarian malignancies. J Tongji Med Univ 1991; 11: 235-9; PMID: 1668016.
    • (1991) J Tongji Med Univ , vol.11 , pp. 235-239
    • Ma, D.1    Gu, M.J.2
  • 15
    • 18144392697 scopus 로고    scopus 로고
    • Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma
    • PMID: 15699022
    • Raspollini MR, Castiglione F, Rossi Degl'innocenti D, Amunni G, Villanucci A, Garbini F, Baroni G, Taddei GL. Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma. Ann Oncol 2005; 16: 590-6; PMID: 15699022; http://dx. doi. org/10. 109/3annonc/mdi112.
    • (2005) Ann Oncol , vol.16 , pp. 590-596
    • Raspollini, M.R.1    Castiglione, F.2    Rossi Degl'innocenti, D.3    Amunni, G.4    Villanucci, A.5    Garbini, F.6    Baroni, G.7    Taddei, G.L.8
  • 16
    • 38649133581 scopus 로고    scopus 로고
    • Prognostic significance of CD3C tumor-infiltrating lymphocytes in ovarian carcinoma
    • PMID: 18037158
    • Tomsova M, Melichar B, Sedlakova I, Steiner I. Prognostic significance of CD3C tumor-infiltrating lymphocytes in ovarian carcinoma. Gynecol Oncol 2008; 108: 415-20; PMID: 18037158; http://dx. doi. org/10. 1016/j. ygyno. 2007. 10. 016.
    • (2008) Gynecol Oncol , vol.108 , pp. 415-420
    • Tomsova, M.1    Melichar, B.2    Sedlakova, I.3    Steiner, I.4
  • 17
    • 29444442811 scopus 로고    scopus 로고
    • Intraepithelial CD8C tumor-infiltrating lymphocytes and a high CD8C/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
    • PMID: 16344461
    • Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, et al. Intraepithelial CD8C tumor-infiltrating lymphocytes and a high CD8C/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 2005; 102: 18538-43; PMID: 16344461; http://dx. doi. org/10. 1073/pnas. 0509182102.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 18538-18543
    • Sato, E.1    Olson, S.H.2    Ahn, J.3    Bundy, B.4    Nishikawa, H.5    Qian, F.6    Jungbluth, A.A.7    Frosina, D.8    Gnjatic, S.9    Ambrosone, C.10
  • 18
    • 0344406265 scopus 로고    scopus 로고
    • Association of ovarian tumor epithelium coexpressing HLA-DR and CA-125 antigens with tumor infiltrating cytotoxic T lymphocytes
    • PMID: 12646975
    • Matsushita N, Ghazizadeh M, Konishi H, Araki T. Association of ovarian tumor epithelium coexpressing HLA-DR and CA-125 antigens with tumor infiltrating cytotoxic T lymphocytes. J Nippon Med Sch 2003; 70: 40-4; PMID: 12646975; http://dx. doi. org/10. 1272/jnms. 70. 40.
    • (2003) J Nippon Med Sch , vol.70 , pp. 40-44
    • Matsushita, N.1    Ghazizadeh, M.2    Konishi, H.3    Araki, T.4
  • 19
    • 33847611968 scopus 로고    scopus 로고
    • Programmed cell death 1 ligand 1 and tumor-infiltrating CD8C T lymphocytes are prognostic factors of human ovarian cancer
    • PMID: 17360651
    • Hamanishi J, Mandai M, Iwasaki M, Okazaki T, Tanaka Y, Yamaguchi K, Higuchi T, Yagi H, Takakura K, Minato N, et al. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8C T lymphocytes are prognostic factors of human ovarian cancer. Proc Natl Acad Sci U S A 2007; 104: 3360-5; PMID: 17360651; http://dx. doi. org/10. 1073/pnas. 0611533104.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 3360-3365
    • Hamanishi, J.1    Mandai, M.2    Iwasaki, M.3    Okazaki, T.4    Tanaka, Y.5    Yamaguchi, K.6    Higuchi, T.7    Yagi, H.8    Takakura, K.9    Minato, N.10
  • 20
    • 59449090208 scopus 로고    scopus 로고
    • Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer
    • PMID: 19047092
    • Callahan MJ, Nagymanyoki Z, Bonome T, Johnson ME, Litkouhi B, Sullivan EH, Hirsch MS, Matulonis UA, Liu J, Birrer MJ, et al. Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer. Clin Cancer Res 2008; 14: 7667-73; PMID: 19047092; http://dx. doi. org/10. 1158/1078-0432. CCR-08-0479.
    • (2008) Clin Cancer Res , vol.14 , pp. 7667-7673
    • Callahan, M.J.1    Nagymanyoki, Z.2    Bonome, T.3    Johnson, M.E.4    Litkouhi, B.5    Sullivan, E.H.6    Hirsch, M.S.7    Matulonis, U.A.8    Liu, J.9    Birrer, M.J.10
  • 21
    • 67649624673 scopus 로고    scopus 로고
    • Intraepithelial T cells and tumor proliferation: Impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer
    • PMID: 19472394
    • Adams SF, Levine DA, Cadungog MG, Hammond R, Facciabene A, Olvera N, Rubin SC, Boyd J, Gimotty PA, Coukos G. Intraepithelial T cells and tumor proliferation: impact on the benefit from surgical cytoreduction in advanced serous ovarian cancer. Cancer 2009; 115: 2891-902; PMID: 19472394; http://dx. doi. org/10. 1002/cncr. 24317.
    • (2009) Cancer , vol.115 , pp. 2891-2902
    • Adams, S.F.1    Levine, D.A.2    Cadungog, M.G.3    Hammond, R.4    Facciabene, A.5    Olvera, N.6    Rubin, S.C.7    Boyd, J.8    Gimotty, P.A.9    Coukos, G.10
  • 23
    • 70350657101 scopus 로고    scopus 로고
    • Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: Relevance of clonal selection of T lymphocytes
    • PMID: 19861998
    • Stumpf M, Hasenburg A, Riener MO, Jutting U, Wang C, Shen Y, Orlowska-Volk M, Fisch P, Wang Z, Gitsch G, et al. Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes. Br J Cancer 2009; 101: 1513-21; PMID: 19861998; http://dx. doi. org/10. 1038/sj. bjc. 6605274.
    • (2009) Br J Cancer , vol.101 , pp. 1513-1521
    • Stumpf, M.1    Hasenburg, A.2    Riener, M.O.3    Jutting, U.4    Wang, C.5    Shen, Y.6    Orlowska-Volk, M.7    Fisch, P.8    Wang, Z.9    Gitsch, G.10
  • 25
    • 81355160439 scopus 로고    scopus 로고
    • The comprehensive assessment of local immune status of ovarian cancer by the clustering of multiple immune factors
    • PMID: 21955569
    • Hamanishi J, Mandai M, Abiko K, Matsumura N, Baba T, Yoshioka Y, Kosaka K, Konishi I. The comprehensive assessment of local immune status of ovarian cancer by the clustering of multiple immune factors. Clin Immunol 2011; 141: 338-47; PMID: 21955569; http://dx. doi. org/10. 1016/j. clim. 2011. 08. 013.
    • (2011) Clin Immunol , vol.141 , pp. 338-347
    • Hamanishi, J.1    Mandai, M.2    Abiko, K.3    Matsumura, N.4    Baba, T.5    Yoshioka, Y.6    Kosaka, K.7    Konishi, I.8
  • 26
    • 79959775835 scopus 로고    scopus 로고
    • Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression
    • PMID: 21654520
    • Vermeij R, de Bock GH, Leffers N, Ten Hoor KA, Schulze U, Hollema H, van der Burg SH, van der Zee AG, Daemen T, Nijman HW. Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression. J Immunother 2011; 34: 516-23; PMID: 21654520; http://dx. doi. org/10. 1097/CJI. 0b013e31821e012f.
    • (2011) J Immunother , vol.34 , pp. 516-523
    • Vermeij, R.1    de Bock, G.H.2    Leffers, N.3    Ten Hoor, K.A.4    Schulze, U.5    Hollema, H.6    van der Burg, S.H.7    van der Zee, A.G.8    Daemen, T.9    Nijman, H.W.10
  • 27
    • 84857376683 scopus 로고    scopus 로고
    • Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes
    • PMID: 22369276
    • Milne K, Alexander C, Webb JR, Sun W, Dillon K, Kalloger SE, Gilks CB, Clarke B, Kobel M, Nelson BH. Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes. J Transl Med 2012; 10: 33; PMID: 22369276; http://dx. doi. org/10. 1186/1479-5876-10-33.
    • (2012) J Transl Med , vol.10 , pp. 33
    • Milne, K.1    Alexander, C.2    Webb, J.R.3    Sun, W.4    Dillon, K.5    Kalloger, S.E.6    Gilks, C.B.7    Clarke, B.8    Kobel, M.9    Nelson, B.H.10
  • 28
    • 84862557227 scopus 로고    scopus 로고
    • CD20C tumor-infiltrating lymphocytes have an atypical CD27-memory phenotype and together with CD8C T cells promote favorable prognosis in ovarian cancer
    • PMID: 22553348
    • Nielsen JS, Sahota RA, Milne K, Kost SE, Nesslinger NJ, Watson PH, Nelson BH. CD20C tumor-infiltrating lymphocytes have an atypical CD27-memory phenotype and together with CD8C T cells promote favorable prognosis in ovarian cancer. Clin Cancer Res 2012; 18: 3281-92; PMID: 22553348; http://dx. doi. org/10. 1158/1078-0432. CCR-12-0234.
    • (2012) Clin Cancer Res , vol.18 , pp. 3281-3292
    • Nielsen, J.S.1    Sahota, R.A.2    Milne, K.3    Kost, S.E.4    Nesslinger, N.J.5    Watson, P.H.6    Nelson, B.H.7
  • 29
    • 61349167118 scopus 로고    scopus 로고
    • Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: High expression of ULBP2 is an indicator of poor prognosis
    • PMID: 18791713
    • Li K, Mandai M, Hamanishi J, Matsumura N, Suzuki A, Yagi H, Yamaguchi K, Baba T, Fujii S, Konishi I. Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis. Cancer Immunol Immunother 2009; 58: 641-52; PMID: 18791713; http://dx. doi. org/10. 1007/s00262-008-0585-3.
    • (2009) Cancer Immunol Immunother , vol.58 , pp. 641-652
    • Li, K.1    Mandai, M.2    Hamanishi, J.3    Matsumura, N.4    Suzuki, A.5    Yagi, H.6    Yamaguchi, K.7    Baba, T.8    Fujii, S.9    Konishi, I.10
  • 30
    • 61349197486 scopus 로고    scopus 로고
    • Classification using hierarchical clustering of tumorinfiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression
    • PMID: 18997734
    • Liu M, Matsumura N, Mandai M, Li K, Yagi H, Baba T, Suzuki A, Hamanishi J, Fukuhara K, Konishi I. Classification using hierarchical clustering of tumorinfiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression. Mod Pathol 2009; 22: 373-84; PMID: 18997734; http://dx. doi. org/10. 1038/modpathol. 2008. 187.
    • (2009) Mod Pathol , vol.22 , pp. 373-384
    • Liu, M.1    Matsumura, N.2    Mandai, M.3    Li, K.4    Yagi, H.5    Baba, T.6    Suzuki, A.7    Hamanishi, J.8    Fukuhara, K.9    Konishi, I.10
  • 32
    • 50349084447 scopus 로고    scopus 로고
    • HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma
    • PMID: 18519766
    • Han LY, Fletcher MS, Urbauer DL, Mueller P, Landen CN, Kamat AA, Lin YG, Merritt WM, Spannuth WA, Deavers MT, et al. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma. Clin Cancer Res 2008; 14: 3372-9; PMID: 18519766; http://dx. doi. org/10. 1158/1078-0432. CCR-07-4433.
    • (2008) Clin Cancer Res , vol.14 , pp. 3372-3379
    • Han, L.Y.1    Fletcher, M.S.2    Urbauer, D.L.3    Mueller, P.4    Landen, C.N.5    Kamat, A.A.6    Lin, Y.G.7    Merritt, W.M.8    Spannuth, W.A.9    Deavers, M.T.10
  • 33
    • 68149141666 scopus 로고    scopus 로고
    • Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors
    • PMID: 19641607
    • Milne K, Kobel M, Kalloger SE, Barnes RO, Gao D, Gilks CB, Watson PH, Nelson BH. Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PloS one 2009; 4: e6412; PMID: 19641607; http://dx. doi. org/10. 1371/journal. pone. 0006412.
    • (2009) PloS one , vol.4
    • Milne, K.1    Kobel, M.2    Kalloger, S.E.3    Barnes, R.O.4    Gao, D.5    Gilks, C.B.6    Watson, P.H.7    Nelson, B.H.8
  • 34
    • 61349151645 scopus 로고    scopus 로고
    • Intraepithelial T cells and prognosis in ovarian carcinoma: Novel associations with stage, tumor type, and BRCA1 loss
    • PMID: 19060844
    • Clarke B, Tinker AV, Lee CH, Subramanian S, van de Rijn M, Turbin D, Kalloger S, Han G, Ceballos K, Cadungog MG, et al. Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss. Mod Pathol 2009; 22: 393-402; PMID: 19060844; http://dx. doi. org/10. 1038/modpathol. 2008. 191.
    • (2009) Mod Pathol , vol.22 , pp. 393-402
    • Clarke, B.1    Tinker, A.V.2    Lee, C.H.3    Subramanian, S.4    van de Rijn, M.5    Turbin, D.6    Kalloger, S.7    Han, G.8    Ceballos, K.9    Cadungog, M.G.10
  • 35
    • 73349114891 scopus 로고    scopus 로고
    • Study of T lymphocytes infiltrating peritoneal metastases in advanced ovarian cancer: Associations with vascular endothelial growth factor levels and prognosis in patients receiving platinum-based chemotherapy
    • PMID: 20009885
    • Tsiatas ML, Gyftaki R, Liacos C, Politi E, Rodolakis A, Dimopoulos MA, Bamias A. Study of T lymphocytes infiltrating peritoneal metastases in advanced ovarian cancer: associations with vascular endothelial growth factor levels and prognosis in patients receiving platinum-based chemotherapy. Int J Gynecol Cancer 2009; 19: 1329-34; PMID: 20009885; http://dx. doi. org/10. 1111/IGC. 0b013e3181b7a40e.
    • (2009) Int J Gynecol Cancer , vol.19 , pp. 1329-1334
    • Tsiatas, M.L.1    Gyftaki, R.2    Liacos, C.3    Politi, E.4    Rodolakis, A.5    Dimopoulos, M.A.6    Bamias, A.7
  • 36
    • 84862023293 scopus 로고    scopus 로고
    • BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis
    • PMID: 22685580
    • Le Page C, Marineau A, Bonza PK, Rahimi K, Cyr L, Labouba I, Madore J, Delvoye N, Mes-Masson AM, Provencher DM, et al. BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis. PloS One 2012; 7: e38541; PMID: 22685580; http://dx. doi. org/10. 1371/journal. pone. 0038541.
    • (2012) PloS One , vol.7
    • Le Page, C.1    Marineau, A.2    Bonza, P.K.3    Rahimi, K.4    Cyr, L.5    Labouba, I.6    Madore, J.7    Delvoye, N.8    Mes-Masson, A.M.9    Provencher, D.M.10
  • 37
    • 77954723327 scopus 로고    scopus 로고
    • CD4C T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells
    • Nesbeth YC, Martinez DG, Toraya S, Scarlett UK, Cubillos-Ruiz JR, Rutkowski MR, Conejo-Garcia JR. CD4C T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells. J Immunol 2010; 184: 5654-62; http://dx. doi. org/10. 4049/jimmunol. 0903247.
    • (2010) J Immunol , vol.184 , pp. 5654-5662
    • Nesbeth, Y.C.1    Martinez, D.G.2    Toraya, S.3    Scarlett, U.K.4    Cubillos-Ruiz, J.R.5    Rutkowski, M.R.6    Conejo-Garcia, J.R.7
  • 38
    • 42749092358 scopus 로고    scopus 로고
    • Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: Association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer
    • PMID: 18314181
    • Shah CA, Allison KH, Garcia RL, Gray HJ, Goff BA, Swisher EM. Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. Gynecol Oncol 2008; 109: 215-9; PMID: 18314181; http://dx. doi. org/10. 1016/j. ygyno. 2008. 01. 010.
    • (2008) Gynecol Oncol , vol.109 , pp. 215-219
    • Shah, C.A.1    Allison, K.H.2    Garcia, R.L.3    Gray, H.J.4    Goff, B.A.5    Swisher, E.M.6
  • 39
    • 77956873287 scopus 로고    scopus 로고
    • T cell density and location can influence the prognosis of ovarian cancer
    • PMID: 20024633
    • Al-Attar A, Shehata M, Durrant L, Moseley P, Deen S, Chan S. T cell density and location can influence the prognosis of ovarian cancer. Pathol Oncol Res 2010; 16: 361-70; PMID: 20024633; http://dx. doi. org/10. 1007/s12253-009-9230-5.
    • (2010) Pathol Oncol Res , vol.16 , pp. 361-370
    • Al-Attar, A.1    Shehata, M.2    Durrant, L.3    Moseley, P.4    Deen, S.5    Chan, S.6
  • 40
    • 33644652161 scopus 로고    scopus 로고
    • NK-and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma
    • PMID: 16613351
    • Dong HP, Elstrand MB, Holth A, Silins I, Berner A, Trope CG, Davidson B, Risberg B. NK-and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma. Am J Clin Pathol 2006; 125: 451-8; PMID: 16613351; http://dx. doi. org/10. 1309/15B66DQMFYYM78CJ.
    • (2006) Am J Clin Pathol , vol.125 , pp. 451-458
    • Dong, H.P.1    Elstrand, M.B.2    Holth, A.3    Silins, I.4    Berner, A.5    Trope, C.G.6    Davidson, B.7    Risberg, B.8
  • 41
    • 84856021596 scopus 로고    scopus 로고
    • Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
    • PMID: 22040834
    • Hwang WT, Adams SF, Tahirovic E, Hagemann IS, Coukos G. Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecol Oncol 2012; 124: 192-8; PMID: 22040834; http://dx. doi. org/10. 1016/j. ygyno. 2011. 09. 039.
    • (2012) Gynecol Oncol , vol.124 , pp. 192-198
    • Hwang, W.T.1    Adams, S.F.2    Tahirovic, E.3    Hagemann, I.S.4    Coukos, G.5
  • 43
    • 84865747539 scopus 로고    scopus 로고
    • CXCR3C T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity
    • PMID: 22798340
    • Redjimi N, Raffin C, Raimbaud I, Pignon P, Matsuzaki J, Odunsi K, Valmori D, Ayyoub M. CXCR3C T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity. Cancer Res 2012; 72: 4351-60; PMID: 22798340; http://dx. doi. org/10. 1158/0008-5472. CAN-12-0579.
    • (2012) Cancer Res , vol.72 , pp. 4351-4360
    • Redjimi, N.1    Raffin, C.2    Raimbaud, I.3    Pignon, P.4    Matsuzaki, J.5    Odunsi, K.6    Valmori, D.7    Ayyoub, M.8
  • 44
    • 65949111746 scopus 로고    scopus 로고
    • FOXP3 defines regulatory T cells in human tumor and autoimmune disease
    • PMID: 19383912
    • Kryczek I, Liu R, Wang G, Wu K, Shu X, Szeliga W, Vatan L, Finlayson E, Huang E, Simeone D, et al. FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Res 2009; 69: 3995-4000; PMID: 19383912; http://dx. doi. org/10. 1158/0008-5472. CAN-08-3804.
    • (2009) Cancer Res , vol.69 , pp. 3995-4000
    • Kryczek, I.1    Liu, R.2    Wang, G.3    Wu, K.4    Shu, X.5    Szeliga, W.6    Vatan, L.7    Finlayson, E.8    Huang, E.9    Simeone, D.10
  • 46
    • 4644237613 scopus 로고    scopus 로고
    • Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
    • PMID: 15322536
    • Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-9; PMID: 15322536; http://dx. doi. org/10. 1038/nm1093.
    • (2004) Nat Med , vol.10 , pp. 942-949
    • Curiel, T.J.1    Coukos, G.2    Zou, L.3    Alvarez, X.4    Cheng, P.5    Mottram, P.6    Evdemon-Hogan, M.7    Conejo-Garcia, J.R.8    Zhang, L.9    Burow, M.10
  • 47
    • 34548798737 scopus 로고    scopus 로고
    • Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma
    • PMID: 17875732
    • Kryczek I, Wei S, Zhu G, Myers L, Mottram P, Cheng P, Chen L, Coukos G, Zou W. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res 2007; 67: 8900-5; PMID: 17875732; http://dx. doi. org/10. 1158/0008-5472. CAN-07-1866.
    • (2007) Cancer Res , vol.67 , pp. 8900-8905
    • Kryczek, I.1    Wei, S.2    Zhu, G.3    Myers, L.4    Mottram, P.5    Cheng, P.6    Chen, L.7    Coukos, G.8    Zou, W.9
  • 48
    • 68549132400 scopus 로고    scopus 로고
    • Ovarian cancerassociated ascites demonstrates altered immune environment: Implications for antitumor immunity
    • PMID: 19661290
    • Giuntoli RL, 2nd, Webb TJ, Zoso A, Rogers O, Diaz-Montes TP, Bristow RE, Oelke M. Ovarian cancerassociated ascites demonstrates altered immune environment: implications for antitumor immunity. Anticancer Res 2009; 29: 2875-84; PMID: 19661290.
    • (2009) Anticancer Res , vol.29 , pp. 2875-2884
    • Giuntoli, R.L.1    Webb, T.J.2    Zoso, A.3    Rogers, O.4    Diaz-Montes, T.P.5    Bristow, R.E.6    Oelke, M.7
  • 49
    • 28544433483 scopus 로고    scopus 로고
    • The expression of the regulatory T cellspecific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer
    • PMID: 16322292
    • Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, Muller-Holzner E, Deibl M, Gastl G, Gunsilius E, Marth C. The expression of the regulatory T cellspecific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 2005; 11: 8326-31; PMID: 16322292; http://dx. doi. org/10. 1158/1078-0432. CCR-05-1244.
    • (2005) Clin Cancer Res , vol.11 , pp. 8326-8331
    • Wolf, D.1    Wolf, A.M.2    Rumpold, H.3    Fiegl, H.4    Zeimet, A.G.5    Muller-Holzner, E.6    Deibl, M.7    Gastl, G.8    Gunsilius, E.9    Marth, C.10
  • 51
    • 84872872011 scopus 로고    scopus 로고
    • Dynamics of T-cell infiltration during the course of ovarian cancer: The gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells
    • PMID: 22865582
    • Fialova A, Partlova S, Sojka L, Hromadkova H, Brtnicky T, Fucikova J, Kocian P, Rob L, Bartunkova J, Spisek R. Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells. Int J Cancer 2013; 132: 1070-9; PMID: 22865582; http://dx. doi. org/10. 1002/ijc. 27759.
    • (2013) Int J Cancer , vol.132 , pp. 1070-1079
    • Fialova, A.1    Partlova, S.2    Sojka, L.3    Hromadkova, H.4    Brtnicky, T.5    Fucikova, J.6    Kocian, P.7    Rob, L.8    Bartunkova, J.9    Spisek, R.10
  • 52
    • 77953095652 scopus 로고    scopus 로고
    • Foxp3(C) cell infiltration and granzyme B(C)/Foxp3(C) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma
    • PMID: 20087581
    • Polcher M, Braun M, Friedrichs N, Rudlowski C, Bercht E, Fimmers R, Sauerwald A, Keyver-Paik MD, Kubler K, Buttner R, et al. Foxp3(C) cell infiltration and granzyme B(C)/Foxp3(C) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma. Cancer Immunol Immunother 2010; 59: 909-19; PMID: 20087581; http://dx. doi. org/10. 1007/s00262-010-0817-1.
    • (2010) Cancer Immunol Immunother , vol.59 , pp. 909-919
    • Polcher, M.1    Braun, M.2    Friedrichs, N.3    Rudlowski, C.4    Bercht, E.5    Fimmers, R.6    Sauerwald, A.7    Keyver-Paik, M.D.8    Kubler, K.9    Buttner, R.10
  • 53
  • 54
    • 77950189167 scopus 로고    scopus 로고
    • Ovarian cancer creates a suppressive microenvironment to escape immune elimination
    • PMID: 20144842
    • Yigit R, Massuger LF, Figdor CG, Torensma R. Ovarian cancer creates a suppressive microenvironment to escape immune elimination. Gynecol Oncol 2010; 117: 366-72; PMID: 20144842; http://dx. doi. org/10. 1016/j. ygyno. 2010. 01. 019.
    • (2010) Gynecol Oncol , vol.117 , pp. 366-372
    • Yigit, R.1    Massuger, L.F.2    Figdor, C.G.3    Torensma, R.4
  • 55
  • 56
    • 84883244497 scopus 로고    scopus 로고
    • Tumor-infiltrating B cells and T cells: Working together to promote patient survival
    • PMID: 23264915
    • Nielsen JS, Nelson BH. Tumor-infiltrating B cells and T cells: Working together to promote patient survival. Oncoimmunology 2012; 1: 1623-5; PMID: 23264915; http://dx. doi. org/10. 4161/onci. 21650.
    • (2012) Oncoimmunology , vol.1 , pp. 1623-1625
    • Nielsen, J.S.1    Nelson, B.H.2
  • 57
    • 77951714425 scopus 로고    scopus 로고
    • Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients
    • PMID: 20406835
    • Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O, Hershkovitz L, Levy D, Kubi A, Hovav E, Chermoshniuk N, et al. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin Cancer Res 2010; 16: 2646-55; PMID: 20406835; http://dx. doi. org/10. 1158/1078-0432. CCR-10-0041.
    • (2010) Clin Cancer Res , vol.16 , pp. 2646-2655
    • Besser, M.J.1    Shapira-Frommer, R.2    Treves, A.J.3    Zippel, D.4    Itzhaki, O.5    Hershkovitz, L.6    Levy, D.7    Kubi, A.8    Hovav, E.9    Chermoshniuk, N.10
  • 59
    • 20244366111 scopus 로고    scopus 로고
    • Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
    • PMID: 15800326
    • Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE, Mavroukakis SA, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 2005; 23: 2346-57; PMID: 15800326; http://dx. doi. org/10. 1200/JCO. 2005. 00. 240.
    • (2005) J Clin Oncol , vol.23 , pp. 2346-2357
    • Dudley, M.E.1    Wunderlich, J.R.2    Yang, J.C.3    Sherry, R.M.4    Topalian, S.L.5    Restifo, N.P.6    Royal, R.E.7    Kammula, U.8    White, D.E.9    Mavroukakis, S.A.10
  • 60
    • 55949125601 scopus 로고    scopus 로고
    • Adoptive cell therapy for patients with metastatic melanoma: Evaluation of intensive myeloablative chemoradiation preparative regimens
    • PMID: 18809613
    • Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U, Robbins PF, Huang J, Citrin DE, Leitman SF, et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol 2008; 26: 5233-9; PMID: 18809613; http://dx. doi. org/10. 1200/JCO. 2008. 16. 5449.
    • (2008) J Clin Oncol , vol.26 , pp. 5233-5239
    • Dudley, M.E.1    Yang, J.C.2    Sherry, R.3    Hughes, M.S.4    Royal, R.5    Kammula, U.6    Robbins, P.F.7    Huang, J.8    Citrin, D.E.9    Leitman, S.F.10
  • 61
    • 10344261422 scopus 로고    scopus 로고
    • Cutting edge: Persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy
    • Robbins PF, Dudley ME, Wunderlich J, El-Gamil M, Li YF, Zhou J, Huang J, Powell DJ, Jr., Rosenberg SA. Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy. J Immunol 2004; 173: 7125-30; http://dx. doi. org/10. 4049/jimmunol. 173. 12. 7125.
    • (2004) J Immunol , vol.173 , pp. 7125-7130
    • Robbins, P.F.1    Dudley, M.E.2    Wunderlich, J.3    El-Gamil, M.4    Li, Y.F.5    Zhou, J.6    Huang, J.7    Powell, D.J.8    Rosenberg, S.A.9
  • 62
    • 65249173447 scopus 로고    scopus 로고
    • Adoptive cell therapy for the treatment of patients with metastatic melanoma
    • PMID: 19304471
    • Rosenberg SA, Dudley ME. Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol 2009; 21: 233-40; PMID: 19304471; http://dx. doi. org/10. 1016/j. coi. 2009. 03. 002.
    • (2009) Curr Opin Immunol , vol.21 , pp. 233-240
    • Rosenberg, S.A.1    Dudley, M.E.2
  • 63
    • 0028069489 scopus 로고
    • Largescale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy
    • PMID: 8308273
    • Freedman RS, Tomasovic B, Templin S, Atkinson EN, Kudelka A, Edwards CL, Platsoucas CD. Largescale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J Immunol Methods 1994; 167: 145-60; PMID: 8308273; http://dx. doi. org/10. 1016/0022-1759(94)90084-1.
    • (1994) J Immunol Methods , vol.167 , pp. 145-160
    • Freedman, R.S.1    Tomasovic, B.2    Templin, S.3    Atkinson, E.N.4    Kudelka, A.5    Edwards, C.L.6    Platsoucas, C.D.7
  • 64
    • 0037829421 scopus 로고    scopus 로고
    • Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
    • PMID: 12843795
    • Dudley ME, Wunderlich JR, Shelton TE, Even J, Rosenberg SA. Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother 2003; 26: 332-42; PMID: 12843795; http://dx. doi. org/10. 1097/00002371-200307000-00005.
    • (2003) J Immunother , vol.26 , pp. 332-342
    • Dudley, M.E.1    Wunderlich, J.R.2    Shelton, T.E.3    Even, J.4    Rosenberg, S.A.5
  • 65
    • 0025859335 scopus 로고
    • Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer
    • PMID: 2004379
    • Aoki Y, Takakuwa K, Kodama S, Tanaka K, Takahashi M, Tokunaga A, Takahashi T. Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer. Cancer Res 1991; 51: 1934-9; PMID: 2004379.
    • (1991) Cancer Res , vol.51 , pp. 1934-1939
    • Aoki, Y.1    Takakuwa, K.2    Kodama, S.3    Tanaka, K.4    Takahashi, M.5    Tokunaga, A.6    Takahashi, T.7
  • 67
    • 0028012082 scopus 로고
    • Immunomodulation in patients with epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes
    • PMID: 8261438
    • Ikarashi H, Fujita K, Takakuwa K, Kodama S, Tokunaga A, Takahashi T, Tanaka K. Immunomodulation in patients with epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes. Cancer Res 1994; 54: 190-6; PMID: 8261438.
    • (1994) Cancer Res , vol.54 , pp. 190-196
    • Ikarashi, H.1    Fujita, K.2    Takakuwa, K.3    Kodama, S.4    Tokunaga, A.5    Takahashi, T.6    Tanaka, K.7
  • 68
    • 0029049890 scopus 로고
    • Prolonged diseasefree period in patients with advanced epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes
    • PMID: 9816009
    • Fujita K, Ikarashi H, Takakuwa K, Kodama S, Tokunaga A, Takahashi T, Tanaka K. Prolonged diseasefree period in patients with advanced epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes. Clin Cancer Res 1995; 1: 501-7; PMID: 9816009.
    • (1995) Clin Cancer Res , vol.1 , pp. 501-507
    • Fujita, K.1    Ikarashi, H.2    Takakuwa, K.3    Kodama, S.4    Tokunaga, A.5    Takahashi, T.6    Tanaka, K.7
  • 69
    • 18844483161 scopus 로고    scopus 로고
    • Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma
    • PMID: 10873077
    • Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, et al. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Clin Cancer Res 2000; 6: 2268-78; PMID: 10873077.
    • (2000) Clin Cancer Res , vol.6 , pp. 2268-2278
    • Freedman, R.S.1    Kudelka, A.P.2    Kavanagh, J.J.3    Verschraegen, C.4    Edwards, C.L.5    Nash, M.6    Levy, L.7    Atkinson, E.N.8    Zhang, H.Z.9    Melichar, B.10
  • 72
    • 25844484607 scopus 로고    scopus 로고
    • Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8C T cells
    • PMID: 16203864
    • Gattinoni L, Finkelstein SE, Klebanoff CA, Antony PA, Palmer DC, Spiess PJ, Hwang LN, Yu Z, Wrzesinski C, Heimann DM, et al. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8C T cells. J Exp Med 2005; 202: 907-12; PMID: 16203864; http://dx. doi. org/10. 1084/jem. 20050732.
    • (2005) J Exp Med , vol.202 , pp. 907-912
    • Gattinoni, L.1    Finkelstein, S.E.2    Klebanoff, C.A.3    Antony, P.A.4    Palmer, D.C.5    Spiess, P.J.6    Hwang, L.N.7    Yu, Z.8    Wrzesinski, C.9    Heimann, D.M.10
  • 73
    • 79961133788 scopus 로고    scopus 로고
    • Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes
    • PMID: 21827675
    • Ye Q, Loisiou M, Levine BL, Suhoski MM, Riley JL, June CH, Coukos G, Powell DJ, Jr. Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes. J Translat Med 2011; 9: 131; PMID: 21827675; http://dx. doi. org/10. 1186/1479-5876-9-131.
    • (2011) J Translat Med , vol.9 , pp. 131
    • Ye, Q.1    Loisiou, M.2    Levine, B.L.3    Suhoski, M.M.4    Riley, J.L.5    June, C.H.6    Coukos, G.7    Powell, D.J.8
  • 74
    • 17044446935 scopus 로고    scopus 로고
    • HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2
    • PMID: 8954611
    • Kooi S, Zhang HZ, Patenia R, Edwards CL, Platsoucas CD, Freedman RS. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2. Cell Immunol 1996; 174: 116-28; PMID: 8954611; http://dx. doi. org/10. 1006/cimm. 1996. 0301.
    • (1996) Cell Immunol , vol.174 , pp. 116-128
    • Kooi, S.1    Zhang, H.Z.2    Patenia, R.3    Edwards, C.L.4    Platsoucas, C.D.5    Freedman, R.S.6
  • 75
    • 78651447793 scopus 로고    scopus 로고
    • Indoleamine 2, 3-dioxygenase and immune tolerance in ovarian cancer
    • PMID: 20930628
    • Ino K. Indoleamine 2, 3-dioxygenase and immune tolerance in ovarian cancer. Curr Opin Obstet Gynecol 2011; 23: 13-8; PMID: 20930628; http://dx. doi. org/10. 1097/GCO. 0b013e3283409c79.
    • (2011) Curr Opin Obstet Gynecol , vol.23 , pp. 13-18
    • Ino, K.1
  • 76
    • 84863354166 scopus 로고    scopus 로고
    • Indoleamine-2, 3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy
    • PMID: 22179492
    • Wang D, Saga Y, Mizukami H, Sato N, Nonaka H, Fujiwara H, Takei Y, Machida S, Takikawa O, Ozawa K, et al. Indoleamine-2, 3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy. Int J Oncol 2012; 40: 929-34; PMID: 22179492.
    • (2012) Int J Oncol , vol.40 , pp. 929-934
    • Wang, D.1    Saga, Y.2    Mizukami, H.3    Sato, N.4    Nonaka, H.5    Fujiwara, H.6    Takei, Y.7    Machida, S.8    Takikawa, O.9    Ozawa, K.10
  • 77
    • 67650422617 scopus 로고    scopus 로고
    • Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2, 3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer
    • PMID: 19491279
    • Qian F, Villella J, Wallace PK, Mhawech-Fauceglia P, Tario JD, Jr., Andrews C, Matsuzaki J, Valmori D, Ayyoub M, Frederick PJ, et al. Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2, 3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer. Cancer Res 2009; 69: 5498-504; PMID: 19491279; http://dx. doi. org/10. 1158/0008-5472. CAN-08-2106.
    • (2009) Cancer Res , vol.69 , pp. 5498-5504
    • Qian, F.1    Villella, J.2    Wallace, P.K.3    Mhawech-Fauceglia, P.4    Tario, J.D.5    Andrews, C.6    Matsuzaki, J.7    Valmori, D.8    Ayyoub, M.9    Frederick, P.J.10
  • 80
    • 68049099399 scopus 로고    scopus 로고
    • Endothelin B receptor, a new target in cancer immune therapy
    • PMID: 19567593
    • Kandalaft LE, Facciabene A, Buckanovich RJ, Coukos G. Endothelin B receptor, a new target in cancer immune therapy. Clin Cancer Res 2009; 15: 4521-8; PMID: 19567593; http://dx. doi. org/10. 1158/1078-0432. CCR-08-0543.
    • (2009) Clin Cancer Res , vol.15 , pp. 4521-4528
    • Kandalaft, L.E.1    Facciabene, A.2    Buckanovich, R.J.3    Coukos, G.4
  • 82
    • 8544283773 scopus 로고    scopus 로고
    • Interferongamma expression is an independent prognostic factor in ovarian cancer
    • PMID: 15547530
    • Marth C, Fiegl H, Zeimet AG, Muller-Holzner E, Deibl M, Doppler W, Daxenbichler G. Interferongamma expression is an independent prognostic factor in ovarian cancer. Am J Obstet Gynecol 2004; 191: 1598-605; PMID: 15547530; http://dx. doi. org/10. 1016/j. ajog. 2004. 05. 007.
    • (2004) Am J Obstet Gynecol , vol.191 , pp. 1598-1605
    • Marth, C.1    Fiegl, H.2    Zeimet, A.G.3    Muller-Holzner, E.4    Deibl, M.5    Doppler, W.6    Daxenbichler, G.7
  • 83
    • 0031056830 scopus 로고    scopus 로고
    • Tumor-host interaction: Analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas
    • PMID: 9042797
    • Merogi AJ, Marrogi AJ, Ramesh R, Robinson WR, Fermin CD, Freeman SM. Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas. Human Pathol 1997; 28: 321-31; PMID: 9042797; http://dx. doi. org/10. 1016/S0046-8177(97)90131-3.
    • (1997) Human Pathol , vol.28 , pp. 321-331
    • Merogi, A.J.1    Marrogi, A.J.2    Ramesh, R.3    Robinson, W.R.4    Fermin, C.D.5    Freeman, S.M.6
  • 84
    • 0035135495 scopus 로고    scopus 로고
    • Regulation of invasion of epithelial ovarian cancer by transforming growth factor-b
    • PMID: 11161867
    • Rodriguez GC, Haisley C, Hurteau J, Moser TL, Whitaker R, Bast RC, Jr., Stack MS. Regulation of invasion of epithelial ovarian cancer by transforming growth factor-b. Gynecol Oncol 2001; 80: 245-53; PMID: 11161867; http://dx. doi. org/10. 1006/gyno. 2000. 6042.
    • (2001) Gynecol Oncol , vol.80 , pp. 245-253
    • Rodriguez, G.C.1    Haisley, C.2    Hurteau, J.3    Moser, T.L.4    Whitaker, R.5    Bast, R.C.6    Stack, M.S.7
  • 85
    • 0031801588 scopus 로고    scopus 로고
    • Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines
    • PMID: 9649178
    • Nash MA, Lenzi R, Edwards CL, Kavanagh JJ, Kudelka AP, Verschraegen CF, Platsoucas CD, Freedman RS. Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines. Clin Exp Immunol 1998; 112: 172-80; PMID: 9649178; http://dx. doi. org/10. 1046/j. 1365-2249. 1998. 00576. x.
    • (1998) Clin Exp Immunol , vol.112 , pp. 172-180
    • Nash, M.A.1    Lenzi, R.2    Edwards, C.L.3    Kavanagh, J.J.4    Kudelka, A.P.5    Verschraegen, C.F.6    Platsoucas, C.D.7    Freedman, R.S.8
  • 86
    • 17844402971 scopus 로고    scopus 로고
    • Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer
    • PMID: 11408737
    • Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman JJ, Smith CV, Pecorelli S, Radominska-Pandya A, Cannon MJ, Parham GP. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer. Gynecol Obstet Invest 2001; 51: 254-61; PMID: 11408737; http://dx. doi. org/10. 1159/000058060.
    • (2001) Gynecol Obstet Invest , vol.51 , pp. 254-261
    • Santin, A.D.1    Hermonat, P.L.2    Ravaggi, A.3    Bellone, S.4    Roman, J.J.5    Smith, C.V.6    Pecorelli, S.7    Radominska-Pandya, A.8    Cannon, M.J.9    Parham, G.P.10
  • 87
    • 79961133788 scopus 로고    scopus 로고
    • Engineered Artificial Antigen Presenting Cells Facilitate Direct and Efficient Expansion of Tumor Infiltrating Lymphocytes
    • PMID: 21827675
    • Ye Q, Loisiou M, Levine BL, Suhoski MM, Riley JL, June CH, Coukos G, Powell DJ, Jr. Engineered Artificial Antigen Presenting Cells Facilitate Direct and Efficient Expansion of Tumor Infiltrating Lymphocytes. J Transl Med 2011; 9: 131; PMID: 21827675; http://dx. doi. org/10. 1186/1479-5876-9-131.
    • (2011) J Transl Med , vol.9 , pp. 131
    • Ye, Q.1    Loisiou, M.2    Levine, B.L.3    Suhoski, M.M.4    Riley, J.L.5    June, C.H.6    Coukos, G.7    Powell, D.J.8
  • 88
    • 33645853780 scopus 로고    scopus 로고
    • B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
    • PMID: 16606666
    • Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P, Brumlik M, Cheng P, Curiel T, Myers L, et al. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 2006; 203: 871-81; PMID: 16606666; http://dx. doi. org/10. 1084/jem. 20050930.
    • (2006) J Exp Med , vol.203 , pp. 871-881
    • Kryczek, I.1    Zou, L.2    Rodriguez, P.3    Zhu, G.4    Wei, S.5    Mottram, P.6    Brumlik, M.7    Cheng, P.8    Curiel, T.9    Myers, L.10
  • 89
    • 84881423899 scopus 로고    scopus 로고
    • Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses
    • PMID: 23722540
    • Dangaj D, Lanitis E, Zhao A, Joshi S, Cheng Y, Sandaltzopoulos R, Ra HJ, Danet-Desnoyers G, Powell DJ, Jr., Scholler N. Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses. Cancer Res 2013; 73: 4820-9; PMID: 23722540; http://dx. doi. org/10. 1158/0008-5472. CAN-12-3457.
    • (2013) Cancer Res , vol.73 , pp. 4820-4829
    • Dangaj, D.1    Lanitis, E.2    Zhao, A.3    Joshi, S.4    Cheng, Y.5    Sandaltzopoulos, R.6    Ra, H.J.7    Danet-Desnoyers, G.8    Powell, D.J.9    Scholler, N.10
  • 90
    • 84856330309 scopus 로고    scopus 로고
    • B7-H4 expression promotes tumorigenesis in ovarian cancer
    • PMID: 19955922
    • Cheng L, Jiang J, Gao R, Wei S, Nan F, Li S, Kong B. B7-H4 expression promotes tumorigenesis in ovarian cancer. Int J Gynecol Cancer 2009; 19: 1481-6; PMID: 19955922; http://dx. doi. org/10. 1111/IGC. 0b013e3181ad0fa2.
    • (2009) Int J Gynecol Cancer , vol.19 , pp. 1481-1486
    • Cheng, L.1    Jiang, J.2    Gao, R.3    Wei, S.4    Nan, F.5    Li, S.6    Kong, B.7
  • 93
    • 33846600398 scopus 로고    scopus 로고
    • The road to recovery: Translating PD-1 biology into clinical benefit
    • PMID: 17188572
    • Riley JL, June CH. The road to recovery: translating PD-1 biology into clinical benefit. Trends Immunol 2007; 28: 48-50; PMID: 17188572; http://dx. doi. org/10. 1016/j. it. 2006. 12. 001.
    • (2007) Trends Immunol , vol.28 , pp. 48-50
    • Riley, J.L.1    June, C.H.2
  • 94
    • 0037438490 scopus 로고    scopus 로고
    • Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: Attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses
    • Bennett F, Luxenberg D, Ling V, Wang IM, Marquette K, Lowe D, Khan N, Veldman G, Jacobs KA, Valge-Archer VE, et al. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J Immunol 2003; 170: 711-8; http://dx. doi. org/10. 4049/jimmunol. 170. 2. 711.
    • (2003) J Immunol , vol.170 , pp. 711-718
    • Bennett, F.1    Luxenberg, D.2    Ling, V.3    Wang, I.M.4    Marquette, K.5    Lowe, D.6    Khan, N.7    Veldman, G.8    Jacobs, K.A.9    Valge-Archer, V.E.10
  • 95
    • 18544380239 scopus 로고    scopus 로고
    • Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
    • PMID: 12091876
    • Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 2002; 8: 793-800; PMID: 12091876; http://dx. doi. org/10. 1038/nm0902-1039c.
    • (2002) Nat Med , vol.8 , pp. 793-800
    • Dong, H.1    Strome, S.E.2    Salomao, D.R.3    Tamura, H.4    Hirano, F.5    Flies, D.B.6    Roche, P.C.7    Lu, J.8    Zhu, G.9    Tamada, K.10
  • 96
    • 70349561448 scopus 로고    scopus 로고
    • PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
    • PMID: 19417208
    • Zhang L, Gajewski TF, Kline J. PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model. Blood 2009; 114: 1545-52; PMID: 19417208; http://dx. doi. org/10. 1182/blood-2009-03-206672.
    • (2009) Blood , vol.114 , pp. 1545-1552
    • Zhang, L.1    Gajewski, T.F.2    Kline, J.3
  • 102
    • 84905753981 scopus 로고    scopus 로고
    • Efficacy and safety of anti-PD-1 antibody (Nivolumab: BMS-936558, ONO-4538) in patients with platinum-resistant ovarian cancer
    • Supplementary Abstract 5511
    • Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Noriomi M, Abiko K, Baba T, Yamaguchi K, Ueda A, et al. Efficacy and safety of anti-PD-1 antibody (Nivolumab: BMS-936558, ONO-4538) in patients with platinum-resistant ovarian cancer. J Clin Oncol 2014; 3s; 5s. Supplementary Abstract 5511.
    • (2014) J Clin Oncol , vol.3 , pp. 5
    • Hamanishi, J.1    Mandai, M.2    Ikeda, T.3    Minami, M.4    Kawaguchi, A.5    Noriomi, M.6    Abiko, K.7    Baba, T.8    Yamaguchi, K.9    Ueda, A.10
  • 103
    • 33644659256 scopus 로고    scopus 로고
    • Principles and use of anti-CTLA4 antibody in human cancer immunotherapy
    • PMID: 16464564
    • Peggs KS, Quezada SA, Korman AJ, Allison JP. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. Curr Opin Immunol 2006; 18: 206-13; PMID: 16464564; http://dx. doi. org/10. 1016/j. coi. 2006. 01. 011.
    • (2006) Curr Opin Immunol , vol.18 , pp. 206-213
    • Peggs, K.S.1    Quezada, S.A.2    Korman, A.J.3    Allison, J.P.4
  • 104
    • 33646794392 scopus 로고    scopus 로고
    • Checkpoint blockade in cancer immunotherapy
    • PMID: 16730267
    • Korman AJ, Peggs KS, Allison JP. Checkpoint blockade in cancer immunotherapy. Adv Immunol 2006; 90: 297-339; PMID: 16730267; http://dx. doi. org/10. 1016/S0065-2776(06)90008-X.
    • (2006) Adv Immunol , vol.90 , pp. 297-339
    • Korman, A.J.1    Peggs, K.S.2    Allison, J.P.3
  • 105
    • 0036301503 scopus 로고    scopus 로고
    • CTLA-4: New insights into its biological function and use in tumor immunotherapy
    • PMID: 12087419
    • Egen JG, Kuhns MS, Allison JP. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 2002; 3: 611-8; PMID: 12087419; http://dx. doi. org/10. 1038/ni0702-611.
    • (2002) Nat Immunol , vol.3 , pp. 611-618
    • Egen, J.G.1    Kuhns, M.S.2    Allison, J.P.3
  • 106
    • 0344341626 scopus 로고    scopus 로고
    • Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
    • PMID: 12682289
    • Hodi FS, Mihm MC, Soiffer RJ, Haluska FG, Butler M, Seiden MV, Davis T, Henry-Spires R, MacRae S, Willman A, et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci U S A 2003; 100: 4712-7; PMID: 12682289; http://dx. doi. org/10. 1073/pnas. 0830997100.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 4712-4717
    • Hodi, F.S.1    Mihm, M.C.2    Soiffer, R.J.3    Haluska, F.G.4    Butler, M.5    Seiden, M.V.6    Davis, T.7    Henry-Spires, R.8    McRae, S.9    Willman, A.10
  • 107
    • 84873129546 scopus 로고    scopus 로고
    • CTLA-4 blockade in tumor models: An overview of preclinical and translational research
    • PMID: 23390376
    • Grosso JF, Jure-Kunkel MN. CTLA-4 blockade in tumor models: an overview of preclinical and translational research. Cancer Immun 2013; 13: 5; PMID: 23390376.
    • (2013) Cancer Immun , vol.13
    • Grosso, J.F.1    Jure-Kunkel, M.N.2
  • 108
    • 42949105127 scopus 로고    scopus 로고
    • Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
    • PMID: 18287062
    • Hodi FS, Butler M, Oble DA, Seiden MV, Haluska FG, Kruse A, Macrae S, Nelson M, Canning C, Lowy I, et al. Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci U S A 2008; 105: 3005-10; PMID: 18287062; http://dx. doi. org/10. 1073/pnas. 0712237105.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , pp. 3005-3010
    • Hodi, F.S.1    Butler, M.2    Oble, D.A.3    Seiden, M.V.4    Haluska, F.G.5    Kruse, A.6    Macrae, S.7    Nelson, M.8    Canning, C.9    Lowy, I.10
  • 109
    • 79952296527 scopus 로고    scopus 로고
    • Immunotherapy for ovarian cancer: What's next?
    • PMID: 21079136
    • Kandalaft LE, Powell DJ, Jr., Singh N, Coukos G. Immunotherapy for ovarian cancer: what's next? J Clin Oncol 2011; 29: 925-33; PMID: 21079136; http://dx. doi. org/10. 1200/JCO. 2009. 27. 2369.
    • (2011) J Clin Oncol , vol.29 , pp. 925-933
    • Kandalaft, L.E.1    Powell, D.J.2    Singh, N.3    Coukos, G.4
  • 110
    • 79955785050 scopus 로고    scopus 로고
    • Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production
    • PMID: 21559358
    • Curran MA, Kim M, Montalvo W, Al-Shamkhani A, Allison JP. Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production. PloS One 2011; 6: e19499; PMID: 21559358; http://dx. doi. org/10. 1371/journal. pone. 0019499.
    • (2011) PloS One , vol.6
    • Curran, M.A.1    Kim, M.2    Montalvo, W.3    Al-Shamkhani, A.4    Allison, J.P.5
  • 111
    • 84879104519 scopus 로고    scopus 로고
    • Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
    • PMID: 23633484
    • Duraiswamy J, Kaluza KM, Freeman GJ, Coukos G. Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors. Cancer Res 2013; 73: 3591-603; PMID: 23633484; http://dx. doi. org/10. 1158/0008-5472. CAN-12-4100.
    • (2013) Cancer Res , vol.73 , pp. 3591-3603
    • Duraiswamy, J.1    Kaluza, K.M.2    Freeman, G.J.3    Coukos, G.4
  • 112
    • 77749279776 scopus 로고    scopus 로고
    • PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
    • PMID: 20160101
    • Curran MA, Montalvo W, Yagita H, Allison JP. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc Natl Acad Sci U S A 2010; 107: 4275-80; PMID: 20160101; http://dx. doi. org/10. 1073/pnas. 0915174107.
    • (2010) Proc Natl Acad Sci U S A , vol.107 , pp. 4275-4280
    • Curran, M.A.1    Montalvo, W.2    Yagita, H.3    Allison, J.P.4
  • 114
    • 84883466843 scopus 로고    scopus 로고
    • A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: From bench to bedside
    • PMID: 23838316
    • Chiang CL, Kandalaft LE, Tanyi J, Hagemann AR, Motz GT, Svoronos N, Montone K, Mantia-Smaldone GM, Smith L, Nisenbaum HL, et al. A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside. Clin Cancer Res 2013; 19: 4801-15; PMID: 23838316; http://dx. doi. org/10. 1158/1078-0432. CCR-13-1185.
    • (2013) Clin Cancer Res , vol.19 , pp. 4801-4815
    • Chiang, C.L.1    Kandalaft, L.E.2    Tanyi, J.3    Hagemann, A.R.4    Motz, G.T.5    Svoronos, N.6    Montone, K.7    Mantia-Smaldone, G.M.8    Smith, L.9    Nisenbaum, H.L.10
  • 115
    • 84874625308 scopus 로고    scopus 로고
    • Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer
    • Kandalaft LE, Powell DJ, Jr., Chiang CL, Tanyi J, Kim S, Bosch M, Montone K, Mick R, Levine BL, Torigian DA, et al. Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer. Oncoimmunology 2013; 2: e22664; http://dx. doi. org/10. 4161/onci. 22664.
    • (2013) Oncoimmunology , vol.2
    • Kandalaft, L.E.1    Powell, D.J.2    Chiang, C.L.3    Tanyi, J.4    Kim, S.5    Bosch, M.6    Montone, K.7    Mick, R.8    Levine, B.L.9    Torigian, D.A.10
  • 116
    • 78449237499 scopus 로고    scopus 로고
    • Clinical experiences with anti-CD137 and anti-PD1 therapeutic antibodies
    • PMID: 21074066
    • Ascierto PA, Simeone E, Sznol M, Fu YX, Melero I. Clinical experiences with anti-CD137 and anti-PD1 therapeutic antibodies. Semin Oncol 2010; 37: 508-16; PMID: 21074066; http://dx. doi. org/10. 1053/j. seminoncol. 2010. 09. 008.
    • (2010) Semin Oncol , vol.37 , pp. 508-516
    • Ascierto, P.A.1    Simeone, E.2    Sznol, M.3    Fu, Y.X.4    Melero, I.5
  • 117
    • 84883853182 scopus 로고    scopus 로고
    • Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer
    • PMID: 24044888
    • Guo Z, Cheng D, Xia Z, Luan M, Wu L, Wang G, Zhang S. Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer. J Translat Med 2013; 11: 215; PMID: 24044888; http://dx. doi. org/10. 1186/1479-5876-11-215.
    • (2013) J Translat Med , vol.11 , pp. 215
    • Guo, Z.1    Cheng, D.2    Xia, Z.3    Luan, M.4    Wu, L.5    Wang, G.6    Zhang, S.7
  • 119
    • 15944410592 scopus 로고    scopus 로고
    • Inhibition of CD4(C) 25C T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
    • PMID: 15591121
    • Lutsiak ME, Semnani RT, De Pascalis R, Kashmiri SV, Schlom J, Sabzevari H. Inhibition of CD4(C) 25C T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 2005; 105: 2862-8; PMID: 15591121; http://dx. doi. org/10. 1182/blood-2004-06-2410.
    • (2005) Blood , vol.105 , pp. 2862-2868
    • Lutsiak, M.E.1    Semnani, R.T.2    De Pascalis, R.3    Kashmiri, S.V.4    Schlom, J.5    Sabzevari, H.6
  • 120
    • 33846878993 scopus 로고    scopus 로고
    • Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, Bcell and T-cell homeostatic proliferation, and specific tumor infiltration
    • PMID: 17255288
    • Bracci L, Moschella F, Sestili P, La Sorsa V, Valentini M, Canini I, Baccarini S, Maccari S, Ramoni C, Belardelli F, et al. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, Bcell and T-cell homeostatic proliferation, and specific tumor infiltration. Clin Cancer Res 2007; 13: 644-53; PMID: 17255288; http://dx. doi. org/10. 1158/1078-0432. CCR-06-1209.
    • (2007) Clin Cancer Res , vol.13 , pp. 644-653
    • Bracci, L.1    Moschella, F.2    Sestili, P.3    La Sorsa, V.4    Valentini, M.5    Canini, I.6    Baccarini, S.7    Maccari, S.8    Ramoni, C.9    Belardelli, F.10
  • 121
    • 10844269645 scopus 로고    scopus 로고
    • Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4CCD25C regulatory T cells
    • Prasad SJ, Farrand KJ, Matthews SA, Chang JH, McHugh RS, Ronchese F. Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4CCD25C regulatory T cells. J Immunol 2005; 174: 90-8; http://dx. doi. org/10. 4049/jimmunol. 174. 1. 90.
    • (2005) J Immunol , vol.174 , pp. 90-98
    • Prasad, S.J.1    Farrand, K.J.2    Matthews, S.A.3    Chang, J.H.4    McHugh, R.S.5    Ronchese, F.6
  • 122
    • 70350496784 scopus 로고    scopus 로고
    • Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells
    • PMID: 19769742
    • Rech AJ, Vonderheide RH. Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells. Ann N Y Acad Sci 2009; 1174: 99-106; PMID: 19769742; http://dx. doi. org/10. 1111/j. 1749-6632. 2009. 04939. x.
    • (2009) Ann N Y Acad Sci , vol.1174 , pp. 99-106
    • Rech, A.J.1    Vonderheide, R.H.2
  • 123
    • 33845675770 scopus 로고    scopus 로고
    • Following anti-CD25 treatment, a functional CD4CCD25C regulatory T-cell pool is present in renal transplant recipients
    • PMID: 17109733
    • Kreijveld E, Koenen HJ, Klasen IS, Hilbrands LB, Joosten I. Following anti-CD25 treatment, a functional CD4CCD25C regulatory T-cell pool is present in renal transplant recipients. Am J Transplant 2007; 7: 249-55; PMID: 17109733; http://dx. doi. org/10. 1111/j. 1600-6143. 2006. 01604. x.
    • (2007) Am J Transplant , vol.7 , pp. 249-255
    • Kreijveld, E.1    Koenen, H.J.2    Klasen, I.S.3    Hilbrands, L.B.4    Joosten, I.5
  • 124
    • 44949111435 scopus 로고    scopus 로고
    • Partial reduction of human FOXP3C CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration
    • PMID: 18481388
    • Powell DJ, Jr., Attia P, Ghetie V, Schindler J, Vitetta ES, Rosenberg SA. Partial reduction of human FOXP3C CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration. J Immunother 2008; 31: 189-98; PMID: 18481388; http://dx. doi. org/10. 1097/CJI. 0b013e31815dc0e8.
    • (2008) J Immunother , vol.31 , pp. 189-198
    • Powell, D.J.1    Attia, P.2    Ghetie, V.3    Schindler, J.4    Vitetta, E.S.5    Rosenberg, S.A.6
  • 125
    • 40749114476 scopus 로고    scopus 로고
    • Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo
    • Powell DJ, Jr., Felipe-Silva A, Merino MJ, Ahmadzadeh M, Allen T, Levy C, White DE, Mavroukakis S, Kreitman RJ, Rosenberg SA, et al. Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo. J Immunol 2007; 179: 4919-28; http://dx. doi. org/10. 4049/jimmunol. 179. 7. 4919.
    • (2007) J Immunol , vol.179 , pp. 4919-4928
    • Powell, D.J.1    Felipe-Silva, A.2    Merino, M.J.3    Ahmadzadeh, M.4    Allen, T.5    Levy, C.6    White, D.E.7    Mavroukakis, S.8    Kreitman, R.J.9    Rosenberg, S.A.10
  • 126
    • 21844471006 scopus 로고    scopus 로고
    • Large-scale depletion of CD25C regulatory T cells from patient leukapheresis samples
    • PMID: 16000960
    • Powell DJ, Jr., Parker LL, Rosenberg SA. Large-scale depletion of CD25C regulatory T cells from patient leukapheresis samples. J Immunother 2005; 28: 403-11; PMID: 16000960; http://dx. doi. org/10. 1097/01. cji. 0000170363. 22585. 5a.
    • (2005) J Immunother , vol.28 , pp. 403-411
    • Powell, D.J.1    Parker, L.L.2    Rosenberg, S.A.3
  • 127
    • 34247559064 scopus 로고    scopus 로고
    • Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy
    • PMID: 17457218
    • Powell DJ, Jr., de Vries CR, Allen T, Ahmadzadeh M, Rosenberg SA. Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy. J Immunother 2007; 30: 438-47; PMID: 17457218; http://dx. doi. org/10. 1097/CJI. 0b013e3180600ff9.
    • (2007) J Immunother , vol.30 , pp. 438-447
    • Powell, D.J.1    de Vries, C.R.2    Allen, T.3    Ahmadzadeh, M.4    Rosenberg, S.A.5
  • 128
    • 63649120341 scopus 로고    scopus 로고
    • Interleukin 2-mediated conversion of ovarian cancer-associated CD4C regulatory T cells into proinflammatory interleukin 17-producing helper T cells
    • PMID: 19238008
    • Leveque L, Deknuydt F, Bioley G, Old LJ, Matsuzaki J, Odunsi K, Ayyoub M, Valmori D. Interleukin 2-mediated conversion of ovarian cancer-associated CD4C regulatory T cells into proinflammatory interleukin 17-producing helper T cells. J Immunother 2009; 32: 101-8; PMID: 19238008; http://dx. doi. org/10. 1097/CJI. 0b013e318195b59e.
    • (2009) J Immunother , vol.32 , pp. 101-108
    • Leveque, L.1    Deknuydt, F.2    Bioley, G.3    Old, L.J.4    Matsuzaki, J.5    Odunsi, K.6    Ayyoub, M.7    Valmori, D.8
  • 129
    • 62749185585 scopus 로고    scopus 로고
    • Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma
    • PMID: 19270751
    • Wallen H, Thompson JA, Reilly JZ, Rodmyre RM, Cao J, Yee C. Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma. PloS One 2009; 4: e4749; PMID: 19270751; http://dx. doi. org/10. 1371/journal. pone. 0004749.
    • (2009) PloS One , vol.4
    • Wallen, H.1    Thompson, J.A.2    Reilly, J.Z.3    Rodmyre, R.M.4    Cao, J.5    Yee, C.6
  • 131
    • 84882453694 scopus 로고    scopus 로고
    • Therapeutic vaccines for ovarian cancer
    • Liao JB, Disis ML. Therapeutic vaccines for ovarian cancer. Gynecol Oncol 2013; 130 (3): 667-73.
    • (2013) Gynecol Oncol , vol.130 , Issue.3 , pp. 667-673
    • Liao, J.B.1    Disis, M.L.2
  • 132
    • 0029117559 scopus 로고
    • Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody
    • PMID: 7674333
    • Canevari S, Stoter G, Arienti F, Bolis G, Colnaghi MI, Di Re EM, Eggermont AM, Goey SH, Gratama JW, Lamers CH, et al. Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody. J Natl Cancer Institute 1995; 87: 1463-9; PMID: 7674333; http://dx. doi. org/10. 1093/jnci/87. 19. 1463.
    • (1995) J Natl Cancer Institute , vol.87 , pp. 1463-1469
    • Canevari, S.1    Stoter, G.2    Arienti, F.3    Bolis, G.4    Colnaghi, M.I.5    Di Re, E.M.6    Eggermont, A.M.7    Goey, S.H.8    Gratama, J.W.9    Lamers, C.H.10
  • 133
    • 67649118309 scopus 로고    scopus 로고
    • Cellular immunotherapy for ovarian cancer
    • PMID: 19456205
    • Cannon MJ, O'Brien TJ. Cellular immunotherapy for ovarian cancer. Expert Opin Biol Ther 2009; 9: 677-88; PMID: 19456205; http://dx. doi. org/10. 1517/14712590902932897.
    • (2009) Expert Opin Biol Ther , vol.9 , pp. 677-688
    • Cannon, M.J.1    O'Brien, T.J.2
  • 134
    • 0024421637 scopus 로고
    • Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: Rationale and preliminary report
    • PMID: 2788602
    • Beller U, Chachoua A, Speyer JL, Sorich J, Dugan M, Liebes L, Hayes R, Beckman EM. Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: rationale and preliminary report. Gynecol Oncol 1989; 34: 407-12; PMID: 2788602; http://dx. doi. org/10. 1016/0090-8258(89)90182-0.
    • (1989) Gynecol Oncol , vol.34 , pp. 407-412
    • Beller, U.1    Chachoua, A.2    Speyer, J.L.3    Sorich, J.4    Dugan, M.5    Liebes, L.6    Hayes, R.7    Beckman, E.M.8
  • 137
    • 0023023119 scopus 로고
    • Intraperitoneal administration of interleukin-2 in patients with cancer
    • PMID: 3491595
    • Lotze MT, Custer MC, Rosenberg SA. Intraperitoneal administration of interleukin-2 in patients with cancer. Arch Surg 1986; 121: 1373-9; PMID: 3491595; http://dx. doi. org/10. 1001/archsurg. 1986. 01400120019002.
    • (1986) Arch Surg , vol.121 , pp. 1373-1379
    • Lotze, M.T.1    Custer, M.C.2    Rosenberg, S.A.3
  • 139
    • 84906253986 scopus 로고    scopus 로고
    • A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytes
    • PMID: 25003657
    • Lanitis E, Smith JB, Dangaj D, Flingai S, Poussin M, Xu S, Czerniecki BJ, Li YF, Robbins PF, Powell DJ, Jr. A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytes. Hum Gene Ther 2014; 25: 730-9; PMID: 25003657; http://dx. doi. org/10. 1089/hum. 2014. 006.
    • (2014) Hum Gene Ther , vol.25 , pp. 730-739
    • Lanitis, E.1    Smith, J.B.2    Dangaj, D.3    Flingai, S.4    Poussin, M.5    Xu, S.6    Czerniecki, B.J.7    Li, Y.F.8    Robbins, P.F.9    Powell, D.J.10
  • 140
    • 79952304769 scopus 로고    scopus 로고
    • Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1
    • PMID: 21282551
    • Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL, et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol 2011; 29: 917-24; PMID: 21282551; http://dx. doi. org/10. 1200/JCO. 2010. 32. 2537.
    • (2011) J Clin Oncol , vol.29 , pp. 917-924
    • Robbins, P.F.1    Morgan, R.A.2    Feldman, S.A.3    Yang, J.C.4    Sherry, R.M.5    Dudley, M.E.6    Wunderlich, J.R.7    Nahvi, A.V.8    Helman, L.J.9    Mackall, C.L.10
  • 141
    • 0034693937 scopus 로고    scopus 로고
    • Expansion and characterization of T cells transduced with a chimeric receptor against ovarian cancer
    • PMID: 11096442
    • Parker LL, Do MT, Westwood JA, Wunderlich JR, Dudley ME, Rosenberg SA, Hwu P. Expansion and characterization of T cells transduced with a chimeric receptor against ovarian cancer. Hum Gene Ther 2000; 11: 2377-87; PMID: 11096442; http://dx. doi. org/10. 1089/104303400750038480.
    • (2000) Hum Gene Ther , vol.11 , pp. 2377-2387
    • Parker, L.L.1    Do, M.T.2    Westwood, J.A.3    Wunderlich, J.R.4    Dudley, M.E.5    Rosenberg, S.A.6    Hwu, P.7
  • 143
    • 79959914449 scopus 로고    scopus 로고
    • In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB)
    • PMID: 21546571
    • Song DG, Ye Q, Carpenito C, Poussin M, Wang LP, Ji C, Figini M, June CH, Coukos G, Powell DJ, Jr. In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB). Cancer Res 2011; 71: 4617-27; PMID: 21546571; http://dx. doi. org/10. 1158/0008-5472. CAN-11-0422.
    • (2011) Cancer Res , vol.71 , pp. 4617-4627
    • Song, D.G.1    Ye, Q.2    Carpenito, C.3    Poussin, M.4    Wang, L.P.5    Ji, C.6    Figini, M.7    June, C.H.8    Coukos, G.9    Powell, D.J.10
  • 144
    • 84864518399 scopus 로고    scopus 로고
    • A phase I clinical trial of adoptive transfer of folate receptor-a redirected autologous T cells for recurrent ovarian cancer
    • PMID: 22863016
    • Kandalaft LE, Powell DJ, Jr., Coukos G. A phase I clinical trial of adoptive transfer of folate receptor-a redirected autologous T cells for recurrent ovarian cancer. J Translat Med 2012; 10: 157; PMID: 22863016; http://dx. doi. org/10. 1186/1479-5876-10-157.
    • (2012) J Translat Med , vol.10 , pp. 157
    • Kandalaft, L.E.1    Powell, D.J.2    Coukos, G.3
  • 146
    • 84856071702 scopus 로고    scopus 로고
    • CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo
    • PMID: 22117050
    • Song DG, Ye Q, Poussin M, Harms GM, Figini M, Powell DJ, Jr. CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo. Blood 2012; 119: 696-706; PMID: 22117050; http://dx. doi. org/10. 1182/blood-2011-03-344275.
    • (2012) Blood , vol.119 , pp. 696-706
    • Song, D.G.1    Ye, Q.2    Poussin, M.3    Harms, G.M.4    Figini, M.5    Powell, D.J.6
  • 147
    • 77952529498 scopus 로고    scopus 로고
    • Adoptive T cell immunotherapy strategies for the treatment of patients with ovarian cancer
    • PMID: 20102688
    • Chekmasova AA, Brentjens RJ. Adoptive T cell immunotherapy strategies for the treatment of patients with ovarian cancer. Discov Med 2010; 9: 62-70; PMID: 20102688.
    • (2010) Discov Med , vol.9 , pp. 62-70
    • Chekmasova, A.A.1    Brentjens, R.J.2
  • 148
    • 84870028125 scopus 로고    scopus 로고
    • Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels
    • PMID: 23189165
    • Lanitis E, Dangaj D, Hagemann IS, Song DG, Best A, Sandaltzopoulos R, Coukos G, Powell DJ, Jr. Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels. PloS One 2012; 7: e49829; PMID: 23189165; http://dx. doi. org/10. 1371/journal. pone. 0049829.
    • (2012) PloS One , vol.7
    • Lanitis, E.1    Dangaj, D.2    Hagemann, I.S.3    Song, D.G.4    Best, A.5    Sandaltzopoulos, R.6    Coukos, G.7    Powell, D.J.8
  • 149
    • 84879838880 scopus 로고    scopus 로고
    • Collaboration of chimeric antigen receptor (CAR)-expressing T cells and host T cells for optimal elimination of established ovarian tumors
    • PMID: 23734311
    • Spear P, Barber A, Sentman CL. Collaboration of chimeric antigen receptor (CAR)-expressing T cells and host T cells for optimal elimination of established ovarian tumors. Oncoimmunology 2013; 2: e23564; PMID: 23734311; http://dx. doi. org/10. 4161/onci. 23564.
    • (2013) Oncoimmunology , vol.2
    • Spear, P.1    Barber, A.2    Sentman, C.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.